My Stroke Team (MYST): Stroke App Pilot Study

NCT02230280 | Completed

• 1 other identifier: STPILOT-134162
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

Most stroke survivors live with other chronic health conditions that can negatively affect their recovery and overall health and well-being. Although stroke care has improved, there are still many challenges to the delivery of community-based stroke care. These challenges include: poor coordination of care across health care providers and settings; limited communication among health care providers; limited use of evidence-based treatment guidelines; difficulties navigating community services and supports; and limited client and family caregiver involvement in making healthcare decisions. The investigators developed a new mobile health (mHealth) application, My Stroke Team (MYST), to address these challenges to improve the overall quality of stroke care at home. This study will expand this work to: 1) explore the feasibility and acceptability of this mobile tool, 2) determine its impact and usability for home care providers, stroke survivors, and their family caregivers, and 3) determine its impact on the costs of use of health services.

Conditions

Stroke; Comorbidity; Chronic Disease

Keywords

Mobile health technology; Multiple chronic conditions; Older adults; Home and community care; Effectiveness; Cost analysis; Interprofessional Stroke Rehabilitation

Outcome Measures

Primary Outcomes (2)

• Changes in health-related quality of life (HRQoL) for both stroke survivors and caregivers as measured by the SF-12

  The Short-Form 12(SF-12) Health Survey will be administered to stroke survivors and caregivers to measure health-related quality of life

  Baseline and the end of the intervention (6 months from baseline)

• Feasibility of the mobile application as part of the intervention.

  Participants' perspectives on the feasibility of the mobile application will be assessed qualitatively through focus groups (HCPs) and interviews (stroke survivors and family caregivers).

  At the end of the intervention (6 months)

Secondary Outcomes (9)

• Changes in the degree of physical functioning related to stroke.

  Baseline and the end of the intervention (6 months from baseline)

• Change in the prevalence and severity of depression symptoms in stroke survivors and family caregivers.

  Baseline and the end of the intervention (6 months from baseline)

• Change in the degree of strain of family caregiver.

  Baseline and the end of the intervention (6months from baseline)

• Change in prevalence and severity of anxiety.

  Baseline and end of intervention (6 months from baseline)

• Change in the self efficacy of stroke survivors.

  Baseline and end of the intervention (6 months from baseline)

Study Arms (1)

The intervention cohort.

OTHER

A community transition and rehabilitation intervention that includes a mobile health solution

Other: Strengthening Community-Based Stroke Care: A Pilot Study of a Community Navigation and Rehabilitation Intervention that Includes a Mobile Health Solution

Interventions

Strengthening Community-Based Stroke Care: A Pilot Study of a Community Navigation and Rehabilitation Intervention that Includes a Mobile Health Solution OTHER

Participants will be offered regular in-home visits over the 6-month study period in addition to usual outpatient rehabilitation services. The health care providers will have access to a mobile health application (MYST) to share real-time information and access community resources and best practice guidelines.

The intervention cohort.

Eligibility Criteria

• Age: 55 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Participants are newly referred for outpatient rehabilitation with a confirmed diagnosis of stroke (first ever or recurrent) within the past 12 months, and are not planning to move away from the community in the next 6 months. Participants have at least 2 predetermined comorbid conditions, and must have the capacity to provide informed consent, either independently or by substitute decision maker.

You may not qualify if:

• Participants will be excluded if they are unable to read and understand English and do not have access to a translator.

Sponsors & Collaborators

• McMaster University: lead

Study Sites (1)

Hamilton Health Sciences

Hamilton, Ontario, L8S 4L8, Canada

Location

MeSH Terms

Conditions

Stroke; Chronic Disease; Multiple Chronic Conditions

Condition Hierarchy (Ancestors)

Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Vascular Diseases; Cardiovascular Diseases; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Maureen Markle-Reid, RN, PhD

  McMaster University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor and Canada Research Chair

Study Record Dates

• First Submitted: August 28, 2014
• First Posted: September 3, 2014
• Study Start: May 8, 2017
• Primary Completion: April 30, 2018
• Study Completion: April 30, 2018
• Last Updated: March 6, 2019

Record last verified: 2019-03

Locations

CA (1)